In contrast, REDD1 is upregulated in various types of cancers, such as myeloid leukemia, glioblastomas, carcinomas, gastric cancers, and breast cancers, resulting in poor prognosis, aggressive malignancy, and reduced overall and disease-free survival in cancer patients152–155. The gene discussed is DDIT4; the disease is breast cancer.